- RJVMF 36 (4) 2022 | Page 28

STUDY
Evolution and therapeutic response in different forms of canine mastocytoma
Tabelele 7 și 8 . Evoluție parametri hematologici
Parametri
20.01.16
22.06.16
08.07.17
10.01.18
26.02.18
26.03.18
Referințe
WBC
8.2
6.8
6.4
6.1
17.7
8.6
6.0-17.0
LIMFOCITE
2.3
2.4
1.2
1.0
2.3
1.9
0.8-5.1
MONOCITE
0.5
0.3
0.2
0.3
0.5
0.3
0.0-1.8
GRAN
5.4
4.1
5
4.8
14.9
6.4
4.0-12.6
LIMFOCITE %
28.5
34.6
18.8
17
13.0
22.6
12.0-30.0
MONOCITE %
5.7
0.3
3.1
4.7
2.8
3.6
2.0-9.0
GRAN %
65.8
60.5
78.1
78.3
84.2
73.8
60.0-83.0
RBC
7.97
7.66
7.11
7.94
6.63
6.99
5.50-8.50
HGB
190
173
162
191
155
159
110-190
HCT
54.5
51.4
48.4
55.1
45.2
47.5
39.0-56.0
MCV
68.4
67.2
68.2
69.5
68.3
68
62.0-72.0
MCH
23.8
22.5
22.7
24
23.3
22.7
20.0-25.0
MCHC
348
336
334
346
342
334
300-380
RDW
12.3
14.1
13.3
13.6
13.3
13.8
11.0-15.5
PLT
67
125
149
274
253
117-460
MPV
7.8
9.0
7.5
8
8.8
7.0-12.9
PDW
16.9
16.4
16.2
16.1
16.2
PCT %
0.052
0.112
0.111
0.219
0.222
EOS %
5.9
1.2
13.2
1.4
1.4
0.1-10
Parametri
19.06.18
09.10.18
20.05.19
09.10.19
27.02.20
4.06.20
25.03.21
Referințe
WBC
7.9
10.6
9.5
7.4
10.5
20.9
13.8
6.0-17.0
LIMFO
1.5
1.2
2.6
1.4
1.7
2.4
1.7
0.8-5.1
MON
0.2
0.3
0.4
0.3
0.4
0.6
0.4
0.0-1.8
GRAN
6.2
9.1
6.5
5.7
8.4
17.9
11.7
4.0-12.6
LIMF %
19.2
11.6
27.1
19.1
16.1
11.7
12.3
12.0-30.0
MON %
3.1
2.7
4.3
4.2
4.0
28
3
2.0-9.0
GRAN %
77.7
85.7
68.6
76.7
79.9
85.5
84.7
60.0-83.0
RBC
6.49
7.11
6.72
6.74
6.7
6.36
6.3
5.50-8.50
HGB
144
170
159
152
165
153
150
110-190
HCT
44.3
49.1
46.1
46.8
49.6
45.4
43.6
39.0-56.0
MCV
68.4
69.1
68.7
69.5
74.1
71.5
69.3
62.0-72.0
MCH
22.1
23.9
23.6
22.5
24.6
24
23.8
20.0-25.0
MCHC
325
346
344
324
332
337
344
300-380
RDW
15.9
13.3
13.1
11.7
10.8
13.1
12.9
11.0-15.5
PLT
229
401
381
117- 460
MPV
7.5
8.3
8.6
7.0- 12.9
PDW
16.6
16.2
16.0
PCT %
0.171
0.332
0.327
EOS %
1.3
2.5
1.6
0.1- 10
214
Vol VII - Nr . 36 ( 4 ) 2022